Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Edwards Lifesciences Corp (NYSE:EW)

During the Trading Day
149.37 -1.72 / -1.14%
As of 4:03pm ET
Day’s Change
During After-Hours   Switch to standard view »
149.48 +0.11 / +0.07%
Volume: 11.5K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 3
Quarter 4
Quarter 1
Quarter 2
Operating ActivitiesNet Income / Starting Line94.6M109.2M123.4M112.7M
Total Other Cash Flow-2.0M14.0M2.5M1.5M
Funds From Operations110.8M68.2M146.0M129.1M
Funds From/For Other Operating Expenses98.6M-25.0M72.7M-41.0M
Net Cash Flow - Operating Activities12.2M93.2M73.3M170.1M
InvestingIncrease In Investments-454.4M-516.2M-509.0M-255.8M
Decrease In Investments317.4M701.4M349.2M292.1M
Capital Expenditures-18.1M-34.5M-20.8M-18.4M
Net Assets From Acquisitions 0.00-15.0M0.000.00
Other Investing - Uses0.00-10.8M0.00-5.1M
Other Investing - Sources300.0K-1.6M300.0K-300.0K
Net Cash Flow Investing-154.8M112.0M-180.3M12.5M
FinancingShort Term Borrowings0.
Long Term Borrowings6.2M6.0M7.4M5.9M
Long Term Debt Reduction-6.1M-20.0M-8.2M-6.5M
Net Proceeds Stock Sale38.4M42.0M23.5M19.0M
Common Preferred Redeemed-100.0K-200.0K-101.0M-78.9M
Common Dividends----------
Cash Dividends Paid - Total0.
Other Sources - Financing12.9M15.2M9.8M9.9M
Other Uses - Financing2.6M-2.9M3.4M0.00
Net Cash Flow - Financing48.7M45.9M-71.9M-50.6M
Exchange RateEffect of Exchange Rate on Cash-600.0K-1.4M-17.9M8.6M
Net Change In Cash-93.9M251.1M-178.9M132.0M